Overview
Financials
Filing timeliness
No financial statement for 2025 – the filing deadline has passed.
- 2025not filed
- 202410/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Offer
- Cronos strain
- Jelly Punch strain
- Lemon Jazz strain
- Magic Power strain
- Papaya Bomb strain
- Purple Cookie strain
- Soho strain
Trademarks
Suprobion holds 9 active trademarks registered with the Polish Patent Office. 3 applications are pending. 1 mark has expired or was not registered. The first mark was filed in 2013.
| Mark | Protected until | |
|---|---|---|
| AksoCYT(word) | Aug 4, 2035 | |
| ZENAMID(word) | Aug 4, 2035 | |
| MioMio Alaskan(word) | Apr 22, 2035 | |
| Suprodril(word) | Dec 9, 2034 | |
| Suprobaza(word) | Dec 6, 2034 |
Authorized Representatives
Manner of representation
Each member of the management board is entitled to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jarosław Sadłekage 63 | 75 | $2,025.93 | 50% |
Wojciech Józef Sadłekage 59 | 75 | $2,025.93 | 50% |
Jarosław Sadłek and Wojciech Józef Sadłek hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-10-01.
88 1240 3464 1978 0010 9081 5394- 34 1240 3464 1787 0010 9081 5440
- 50 1240 3464 1111 0010 9081 5293
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $2,914,449.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 7, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $89,748$89,748 | Polski Fundusz Rozwoju S.A. | |
| Jun 14, 2019 | Aid for research and development projects: industrial research | $2.1M$2,119,876 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 14, 2019 | Aid for research and development projects: experimental development | $655.9K$655,884 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-06-01 | New ophthalmic formulations – multi-ingredient nanoliposomal drops and ointments enriched with non-steroidal anti-inflammatory and antibiotic ingredients | $2.8M$2,824,701 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cefea sp. z o.o.sp. k. | $9,898,555.57 | cefea.pl | ||
| EMO-Farmsp. z o.o. | $8,594,703.16 | emo-farm.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A. | $7,294,338.51 | herbapol.krakow.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| Biovena Healthsp. z o.o. | $6,016,230.67 | biovenahealth.com | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Noris Polskasp. z o.o. | $4,417,954.24 | norispolska.pl | ||
| Langsteinersp. z o.o. | $4,412,556.80 | langsteiner.eu | ||
| Komarkosp. z o.o. | $4,352,872.40 | komarko.pl |
FAQ
Last updated: 2026-04-11